Serine Protease Inhibitor A5
SERPINA5proteinSERPINA5 upregulation in CAD reflects heightened proteolytic and inflammatory activity destabilizing plaques.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleUpregulated in CAD urinary exosomes; protease inhibitor in inflammatory/thrombotic remodeling.
Also acts inCoagulation / thrombus
Druggability
DruggableYes
Known drugs / candidates0
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000188488
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(2)
- A comprehensive proteomic profiling of urinary exosomes and the identification of early non-invasive biomarker in patients with coronary artery disease.Journal of proteomics · 2023 · PMID 38151158 · doi
- Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex.Thrombosis research · 2005 · PMID 16098566 · doi